AK Medical Holdings Limited (HKG:1789)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.880
-0.055 (-1.11%)
Sep 11, 2026, 9:30 AM HKT

AK Medical Holdings Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5531,4821,3461,0941,052761.44
Revenue Growth
4.76%10.11%23.09%3.98%38.16%-26.46%
Gross Profit
974.5897.4808.19674.49636.44499.19
Operating Income
426.86373.88300.78211.48238.3499.44
Net Income
375.2339.09273.93182.1204.7792.62
Earnings Per Share
0.340.300.240.160.180.08
EPS Growth
10.90%24.18%52.50%-11.11%125.00%-71.43%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Elimination of Inter-Segment
-44.67-43.14-43.59-52.21-42.38-51.58
Orthopedic Implants - China
1,4201,3551,226993.59977.67687.41
Orthopedic Implants - United Kingdom
177.36170.6164.2152.49116.76125.62
Total
1,5531,4821,3461,0941,052761.44

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3371,2451,027729.551,045844.23
Total Debt
12.9386.4399.3984.238.7841.56
Net Cash (Debt)
1,3241,159927.29645.351,007802.67
Net Cash Growth
14.23%24.99%43.69%-35.89%25.42%-8.52%
Net Cash Per Share
1.191.040.830.580.900.72

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-395.98451.0733.94242.92176.62
Capital Expenditures
--105.67-152.82-183.8-115.2-58.76
Free Cash Flow
-290.31298.25-149.86127.72117.86
Free Cash Flow Growth
--2.66%--8.36%-1.79%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.75%60.54%60.03%61.66%60.49%65.56%
Operating Margin
27.49%25.22%22.34%19.33%22.66%13.06%
Pretax Margin
28.21%26.64%23.75%21.13%22.84%14.26%
Profit Margin
24.16%22.87%20.34%16.65%19.46%12.16%
FCF Margin
-19.58%22.15%-13.70%12.14%15.48%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1180.1060.0680.0410.0530.020
Dividend Per Share Growth
63.89%56.73%65.64%-23.04%160.59%-39.53%
Dividend Yield
2.38%2.12%1.54%0.75%0.65%0.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.7216.9818.6835.0147.1964.77
Forward PE
10.7215.2215.7720.9837.2332.47
P/FCF Ratio
-19.8317.16-75.6550.90
PS Ratio
3.013.883.805.839.187.88